Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of gimatecan as salvage treatment in advanced breast cancer
2004-005106-79Phase 2Active
- Sponsor
- Sigma-Tau
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gimatecan in breast cancer, sponsored by Sigma-Tau. Primary endpoint: Objective response rate. Started Nov 2005; status: active.
02
Drugs
gimatecan
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-005106-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005106-79.